Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 14 | -507 K | 100% | $49.63 | -$25.1 M |
Net | -14 | -507 K | -100% | -$25.1 M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Brett P. Monia | CEO Level 15, Director | $39 M | -$5.46 M | -12.3% | Feb 29, 2024 |
Hougen Elizabeth L | EVP, Finance & CFO | $10.5 M | -$543 K | -4.91% | Feb 1, 2024 |
Onaiza Cadoret-Manier | EVP, Chf GL Pdt Str & Oper Ofc | $7.95 M | -$386 K | -4.63% | Feb 1, 2024 |
Richard S. Geary | Officer Level 14 | $7.53 M | -$1.52 M | -16.8% | Feb 29, 2024 |
Patrick R. O'neil | EVP CLO & General Counsel | $6.96 M | -$1.89 M | -21.4% | Feb 1, 2024 |
Eugene Schneider | EVP, Chf Clinical Develop Ofcr | $6.93 M | -$2.09 M | -23.2% | Feb 1, 2024 |
Spencer R. Berthelsen | Director | $6.29 M | -$645 K | -9.3% | Jul 1, 2024 |
C. Frank Bennett | Officer Level 14 | $6 M | -$2.88 M | -32.4% | Feb 29, 2024 |
Eric Swayze | Officer Level 14 | $5.72 M | -$2.34 M | -29% | Feb 29, 2024 |
Brian Birchler | EVP, Corp and Development Ops | $5.02 M | -$264 K | -5% | Apr 15, 2024 |
Joseph H. Wender | Director | $4.9 M | Jul 1, 2024 | ||
Joseph Baroldi | EVP, Chief Business Officer | $4.57 M | -$269 K | -5.56% | Apr 15, 2024 |
B. Lynne Parshall | Director | $4.52 M | -$6.39 M | -58.6% | Jul 1, 2024 |
Frederick T. Muto | Director | $3.44 M | Jul 15, 2022 | ||
Joseph Loscalzo | Director | $2.42 M | Jul 1, 2024 | ||
Joan E. Herman | Director | $2.23 M | Jul 1, 2024 | ||
Michael R. Hayden | Director | $1.98 M | Jul 1, 2024 | ||
Peter N. Reikes | Director | $1.25 M | Oct 15, 2021 | ||
Joseph Klein III | Director | $1.06 M | -$596 K | -36% | Jul 1, 2024 |
Allene M. Diaz | Director | $992 K | -$27 K | -2.65% | Jul 1, 2024 |
Michael J. Yang | Director | $398 K | Jul 1, 2024 | ||
Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | $68.5 K | Feb 26, 2024 |
Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
---|